Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
This study has been completed.
Hospital Clinic of Barcelona
First Posted: February 15, 2012
Last Update Posted: April 1, 2015
Information provided by (Responsible Party):
Felipe Garcia, Hospital Clinic of Barcelona